Asklepios BioPharmaceutical, Inc. (AskBio)
Biotechnologieforschung
Research Triangle Park, North Carolina 36.880 Follower:innen
Pioneering science to create transformative molecular medicines.
AskBio Leaders
Our leaders are dedicated to battling the world's rarest diseases.
A World Leader in Molecular Medicine
At AskBio, our gene therapy technology and scientific discoveries are at the center of an entire industry where life-changing genetic medicine has the potential to transform millions of lives around the world. We are conducting groundbreaking research that has paved the way for over 750 patents, state-of-the-art manufacturing, and a broad clinical pipeline of promising gene therapeutics. Learn more about our work here:
Our Pipeline Our Technology PlatformAn Exceptional Place to Grow Your Career
We are a world-class gene therapy organization that embraces diversity and promotes innovative thinking to expand the limits of what is possible. As a leader in molecular medicine, we are continually expanding our team of passionate individuals who are dedicated to innovative scientific discovery and clinical excellence. We wake everyday knowing we can make a difference. At AskBio, our next greatest discovery is right around the corner, and it might just be you. Learn more about AskBio and why:
About AskBio AskBio CareersTransforming Medicine and Changing Lives
At AskBio, our patient-focused innovation, rigorous clinical standards and research, and advocacy collaborations drive the advancement of gene therapies. The transformative power of AAV technology gives hope to patients who suffer from neuromuscular, central nervous system, cardiovascular, metabolic, and other disorders. Learn more about AskFirst and our focus on patients:
AskBio PatientsFirmenfotos
Mitarbeiterperspektiven
-
Thoughts Ahead of ASGCT
Thoughts Ahead of ASGCT
Von Gustavo Pesquin
There are many reasons people dedicate their careers to advancing medical science. Mine have always been rooted in the goal of helping patients fight…
-
Fulfilling the promise of gene therapy
Fulfilling the promise of gene therapy
Von Gustavo Pesquin
About 40 years ago, our Co-Founder and Chief Scientific Officer Jude Samulski achieved an elusive scientific first. He discovered how to clone the…